EU Project PredictND held a general assembly meeting in London
The research project “From Patient Data to Clinical Diagnosis in Neurodegenerative Diseases” (PredictND) held the 6th team and management board meetings at GE Healthcare in Amersham, the UK. The project finished its baseline data collection in June 2016 and is currently analyzing the collected data. There will also be 12-month follow-up data collected with the same subjects. The collected prospective data allows scientific research for improvements in early detection of the neurodegenerative diseases.
The meetings focused on designing the data analyses and forthcoming publications. A risk analysis workshop was also held to map the whole consortium view on possible risks involved in use of the PredictND tool, now that there is experience on its use in the study. In addition to data analysis, the PredictND tool is still being developed further. For example, the user interface has been improved and reporting functionality is being added.
The PredictND project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 611005. The project team consists of from nine European institutes: VTT Technical Research Centre of Finland Ltd. (Finland, co-ordinator), GE Healthcare Ltd (UK), Imperial College London (UK), University of Eastern Finland (Finland), Rigshospitalet/Region Hovestaden (Denmark), VU/VUmc (The Netherlands), University of Perugia (Italy), Alzheimer Europe (Luxembourg), and Combinostics Ltd. (Finland).